Detail akcie Medi-Stim online

Business Summary: Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The Company provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.
Financial Summary: BRIEF: For the six months ended 30 June 2021, Medistim ASArevenues increased 14% to NOK212.4M. Net income applicableto common stockholders increased 35% to NOK56M. Revenuesreflect Probe Sale segment increase of 19% to NOK55.2M,System Sales segment increase of 16% to NOK58.6M, Europesegment increase of 17% to NOK95.1M, USA segment increaseof 18% to NOK76.5M. Net income benefited from OtherOperating Expenses decrease of 54% to NOK12.5M (expense).